Effects of allogeneic bone marrow-derived mesenchymal stem cells on T and B lymphocytes from BXSB mice

被引:110
作者
Deng, WN
Han, Q
Liao, LM
You, SG
Deng, HY [1 ]
Zhao, RCH
机构
[1] Peking Univ, Hlth Sci Ctr, Dept Immunol, Beijing 100083, Peoples R China
[2] Chinese Acad Med Sci, Ctr Tissue Engn, Beijing 100037, Peoples R China
[3] Peking Union Med Coll, Beijing, Peoples R China
[4] Tianjin Med Univ, Dept Immunol, Tianjin, Peoples R China
关键词
D O I
10.1089/dna.2005.24.458
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Bone marrow-derived mesenchymal stem cells (bMSCs) can differentiate into a number of different cell/tissue types, and also possess immunoregulatory functions. The present study was undertaken to elucidate the exact immunoregulatory effects of allogeneic bMSCs on T- and B-lymphocyte proliferation, activation, and function maturation of BXSB mice, which has been considered as a experimental model for human systemic lupus erythematosus (SLE). We determined that bMSCs from BALB/c mice had inhibitory effects on BXSB mice T- lymphocyte proliferation, but no inhibitory effect on their activation. In addition, they had a significant inhibitory and stimulatory effect on IL-4- and IFN-gamma-producing T cells, respectively. Also, bMSCs had inhibitory effects on the proliferation, activation, and IgG secretion of B lymphocytes. In addition, BALB/c bMSCs had an enhancing effect on CD40 expression and inhibitory effects on CD40 ligand (CD40L) ectopic hyperexpression on B cells from BXSB mice.
引用
收藏
页码:458 / 463
页数:6
相关论文
共 26 条
[1]   Quantitative and qualitative analysis of the balance between type 1 and type 2 cytokine-producing CD8- and CD8+ T cells in systemic lupus erythematosus [J].
Amel-Kashipaz, MR ;
Huggins, ML ;
Lanyon, P ;
Robins, A ;
Todd, I ;
Powell, RJ .
JOURNAL OF AUTOIMMUNITY, 2001, 17 (02) :155-163
[2]   Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo [J].
Bartholomew, A ;
Sturgeon, C ;
Siatskas, M ;
Ferrer, K ;
McIntosh, K ;
Patil, S ;
Hardy, W ;
Devine, S ;
Ucker, D ;
Deans, R ;
Moseley, A ;
Hoffman, R .
EXPERIMENTAL HEMATOLOGY, 2002, 30 (01) :42-48
[3]   The expression and significance of intracellular T helper cytokines in systemic lupus erythematosus [J].
Chang, DM ;
Su, WL ;
Chu, SJ .
IMMUNOLOGICAL INVESTIGATIONS, 2002, 31 (01) :1-12
[4]  
Chen SL, 2000, CHINESE MED J-PEKING, V113, P877
[5]   Increased interferon-gamma (IFN-γ), IL-10 and decreased IL-4 mRNA expression in peripheral blood mononuclear cells (PBMC) from patients with systemic lupus erythematosus (SLE) [J].
Csiszár, A ;
Nagy, G ;
Gergely, P ;
Pozsonyi, T ;
Pócsik, É .
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2000, 122 (03) :464-470
[6]  
Fortier LA, 1998, AM J VET RES, V59, P1182
[7]   Increased interleukin-4 production by NK T cells in systemic lupus erythematosus [J].
Funauchi, M ;
Yu, H ;
Sugiyama, M ;
Ikoma, S ;
Ohno, M ;
Kinoshita, K ;
Hamada, K ;
Kanamaru, A .
CLINICAL IMMUNOLOGY, 1999, 92 (02) :197-202
[8]   Immunologic properties of human fetal mesenchymal stem cells [J].
Götherström, C ;
Ringdén, O ;
Tammik, C ;
Zetterberg, E ;
Westgren, M ;
Le Blanc, K .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2004, 190 (01) :239-245
[9]   Immunomodulatory effects of human foetal liver-derived mesenchymal stem cells [J].
Götherström, C ;
Ringdén, O ;
Westgren, M ;
Tammik, C ;
Le Blanc, K .
BONE MARROW TRANSPLANTATION, 2003, 32 (03) :265-272
[10]   Cutting edge: Ectopic expression of CD40 ligand on B cells induces lupus-like autoimmune disease [J].
Higuchi, T ;
Aiba, Y ;
Nomura, T ;
Matsuda, J ;
Mochida, K ;
Suzuki, M ;
Kikutani, H ;
Honjo, T ;
Nishioka, K ;
Tsubata, T .
JOURNAL OF IMMUNOLOGY, 2002, 168 (01) :9-12